Efficacy and safety of Mamajjaka Ghanavati in the treatment of type-2 diabetes mellitus: a prospective open label multi-center clinical study

Clinical Study ◽

Efficacy And Safety ◽

Open Label

Efficacy and safety of Vidangadi Yoga (ayurvedic polyherbal medicine) in type 2 diabetes mellitus: A randomized controlled clinical study

Clinical Trials in Degenerative Diseases ◽

10.4103/2542-3975.248011 ◽

2018 ◽

Vol 3 (4) ◽

pp. 123

Author(s):

ShaileshVinayak Deshpande ◽

KrutikaSubhash Jadhav

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Study ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Controlled Clinical Study

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v2/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Review for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v1/review1 ◽

2019 ◽

Author(s):

Graydon Meneilly

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Preprandial and Prandial Insulin in Combination with Acarbose in Elderly, Insulin-Requiring Patients with Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics ◽

10.1089/dia.2012.0275 ◽

2013 ◽

Vol 15 (6) ◽

pp. 513-519 ◽

Cited By ~ 5

Author(s):

Guang Yang ◽

Chunlin Li ◽

Yanping Gong ◽

Jian Li ◽

Xiaoling Cheng ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Prandial Insulin

Efficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: an open label, randomized, active controlled, phase II trial

Clinical Diabetology ◽

10.5603/dk.2016.0015 ◽

2016 ◽

Vol 5 (3) ◽

pp. 88-94 ◽

Cited By ~ 1

Author(s):

Ashish C. Suthar ◽

Anand Deshmukh ◽

Vijaya Babu ◽

Vijaya S. Mohan ◽

Madhukar V. Chavan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Adjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Open Label

Efficacy and Safety of PDM011011 Capsules as Compared to Metformin in Subjects with Type-2 Diabetes Mellitus: An Open-Label, Randomized, Active-Controlled, Multicentric, Phase III Study

Journal of Diabetes Mellitus ◽

10.4236/jdm.2016.61005 ◽

2016 ◽

Vol 06 (01) ◽

pp. 38-48 ◽

Cited By ~ 1

Author(s):

Ashish C. Suthar ◽

Vikas G. Pai ◽

Yogesh Kadam ◽

Aniruddha Tongaonkar ◽

Shailaja Kale ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Study

Author response for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/response1 ◽

2020 ◽

Author(s):

Yasuo Terauchi ◽

Takahiro Nakama ◽

Robert Spranger ◽

Atsushi Amano ◽

Takahiro Inoue ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Review for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v2/review2 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Review for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v1/review2 ◽

2019 ◽

Author(s):

Michael E. Trautmann

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽